Search Press releases Keywords From To 25 Sep 2008 UCB withdraws EU marketing authorisation application for lacosamide in diabetic neuropathic pain Read More 16 Sep 2008 Changes in UCB's Executive Committee Read More 15 Sep 2008 Keppra XR(TM) approved in the U.S. Read More 12 Sep 2008 Information Regarding UCB as an Issuer by Virtue of Articles 15 and 18 of the Law of 2 May 2007 on the Disclosure of Major Holdings, as of 1 September 2008 Read More 3 Sep 2008 Vimpat® Approved in Europe Read More 28 Aug 2008 UCB launches SHAPE, focusing on its Biopharma specialist efforts, and intends to reduce its world-wide workforce Read More Pagination First page Previous page Previous … Page 168 Page 169 Page 170 Page 171 Current page 172 Page 173 Page 174 Page 175 Page 176 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
